68 related articles for article (PubMed ID: 1291124)
21. Comparison of effects of continuous combined transdermal with oral estrogen and oral progestogen replacement therapies on serum lipoproteins and compliance.
Erenus M; Karakoç B; Gürler A
Climacteric; 2001 Sep; 4(3):228-34. PubMed ID: 11588947
[TBL] [Abstract][Full Text] [Related]
22. [An efficacy and tolerance study of transdermal estrogen replacement therapy with the preparation Systen R50 (Cilag)].
Tanchev S; Moskova P
Akush Ginekol (Sofiia); 1995; 34(2):65-7. PubMed ID: 8651434
[TBL] [Abstract][Full Text] [Related]
23. [Morphologic basis of hemorrhage during hormonal therapy in the climacteric syndrome].
Reslová T; Kohoutek M
Cesk Gynekol; 1990 Sep; 55(8):569-72. PubMed ID: 2225114
[TBL] [Abstract][Full Text] [Related]
24. [Percutaneous estrogen therapy in the post-menopausal period].
Keller PJ
Schweiz Med Wochenschr; 1989 Jul; 119(29):999-1004. PubMed ID: 2678438
[TBL] [Abstract][Full Text] [Related]
25. [Urogenital complaints: value of systemic estrogen therapy].
Hänggi W; Dörflinger A
Praxis (Bern 1994); 1997 Aug; 86(33):1260-3. PubMed ID: 9381012
[TBL] [Abstract][Full Text] [Related]
26. Continuation of postmenopausal hormone replacement therapy in a large health maintenance organization: transdermal matrix patch versus oral estrogen therapy.
Ettinger B; Pressman A
Am J Manag Care; 1999 Jun; 5(6):779-85. PubMed ID: 10538456
[TBL] [Abstract][Full Text] [Related]
27. [Topical hormonal treatment and urogenital atrophy].
Sitruk-Ware R; Thomas JL
Praxis (Bern 1994); 1997 Aug; 86(33):1245-8. PubMed ID: 9381009
[TBL] [Abstract][Full Text] [Related]
28. Transdermal sequential and continuous hormone replacement regimens with estradiol and norethisterone acetate in postmenopausal women: effects on the endometrium.
Johannisson E; Holinka CF; Arrenbrecht S
Int J Fertil Womens Med; 1997; 42 Suppl 2():388-98. PubMed ID: 9397386
[TBL] [Abstract][Full Text] [Related]
29. [Systen--transdermal estradiol for substitution following surgical menopause].
Rachev E; Karag'ozov I
Akush Ginekol (Sofiia); 1995; 34(3):74-6. PubMed ID: 8743861
[TBL] [Abstract][Full Text] [Related]
30. Two routes of hormonal replacement therapy in symptomatic menopausal women after kidney transplantation.
Pietrzak B; Wielgos M; Kaminski P; Bobrowska K
Neuro Endocrinol Lett; 2006 Jun; 27(3):387-91. PubMed ID: 16816826
[TBL] [Abstract][Full Text] [Related]
31. Comparison of continuous and sequential transdermal progestogen with sequential oral progestogen in postmenopausal women using continuous transdermal estrogen: vasomotor symptoms, bleeding patterns, and serum lipids.
Rozenberg S; Ylikorkala O; Arrenbrecht S
Int J Fertil Womens Med; 1997; 42 Suppl 2():376-87. PubMed ID: 9397385
[TBL] [Abstract][Full Text] [Related]
32. Comparison of two estradiol transdermal systems (Oesclim 50 and Estraderm TTS 50). I. Tolerability, adhesion and efficacy.
Rozenbaum H; Birkhäuser M; De Nooyer C; Lambotte R; Pornel B; Schneider H; Studd J
Maturitas; 1996 Nov; 25(3):161-73. PubMed ID: 8981333
[TBL] [Abstract][Full Text] [Related]
33. Estrogen therapy: from women's choice to women's preference.
Lachowsky M
Climacteric; 2002 Jun; 5 Suppl 2():46-9. PubMed ID: 12482111
[TBL] [Abstract][Full Text] [Related]
34. Effect of transdermal estrogen therapy on some vasoactive humoral factors and 24-h ambulatory blood pressure in normotensive postmenopausal women.
Zacharieva S; Atanassova I; Kirilov G; Kalinov K; Shigarminova R; Nachev E; Aslanova N
Climacteric; 2002 Sep; 5(3):293-9. PubMed ID: 12419088
[TBL] [Abstract][Full Text] [Related]
35. Estrogen effects on neuroendocrine function: the new challenge of pulsed therapy.
Genazzani AR; Bernardi F
Climacteric; 2002 Jun; 5 Suppl 2():50-6. PubMed ID: 12482112
[TBL] [Abstract][Full Text] [Related]
36. Estrogen augments serotonergic activity in postmenopausal women.
Halbreich U; Rojansky N; Palter S; Tworek H; Hissin P; Wang K
Biol Psychiatry; 1995 Apr; 37(7):434-41. PubMed ID: 7786956
[TBL] [Abstract][Full Text] [Related]
37. Gonadotropin dynamics in women receiving immediate or delayed transdermal estradiol after oophorectomy.
Kamel EM; Maurer SA; Hochler MG; Hoffman DI; Rebar RW
Obstet Gynecol; 1991 Jul; 78(1):98-102. PubMed ID: 1904568
[TBL] [Abstract][Full Text] [Related]
38. Effects on climacteric symptoms, bone and lipoprotein metabolism of hormone replacement therapy delivered by estradiol-releasing intravaginal rings: a pilot study.
Farish E; Barnes JF; Rankin M; Hart DM
Climacteric; 2003 Sep; 6(3):211-20. PubMed ID: 14567769
[TBL] [Abstract][Full Text] [Related]
39. One-year endometrial safety evaluation of a continuous combined transdermal matrix patch delivering low-dose estradiol-norethisterone acetate in postmenopausal women.
Samsioe G; Dvorak V; Genazzani AR; Hamann B; Heikkinen J; Mueck AO; Suzin J; Kawakami FT; Ferreira A; Sun D; Arguinzoniz M
Maturitas; 2007 Jun; 57(2):171-81. PubMed ID: 17317046
[TBL] [Abstract][Full Text] [Related]
40. Comparison of continuation of postmenopausal hormone replacement therapy: transdermal versus oral estrogen.
Ettinger B; Pressman A; Bradley C
Menopause; 1998; 5(3):152-6. PubMed ID: 9774760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
